期刊文献+

hTERTp/TK/pGL3靶向抑制端粒酶活性及其对鼻咽癌干细胞的杀伤作用 被引量:2

Targeted inhibition of hTERTp/TK/pGL3 on telomerase activity and its killing effect on nasopharyngeal cancer stem cells
暂未订购
导出
摘要 目的:探讨hTERTp/TK/pGL3载体靶向抑制端粒酶活性及其杀灭鼻咽癌CD133+干细胞的作用机制。方法:将已构建的hTERTp/TK/pGL3载体及其对照处理因素(CMV/TK/pGL3和TK/pGL3载体)转染至鼻咽癌CD133+干细胞、CD133-肿瘤细胞、人脐静脉内皮细胞(ECV)(对照组)和鼻咽癌SUNE未分选细胞中,采用Stretch PCR法检测4种细胞端粒酶活性改变。MTT法测定CD133+干细胞和ECV细胞存活率。结果:CD133+鼻咽癌干细胞体外培养7d后细胞逐渐增多,CD133+鼻咽癌干细胞体内成瘤实验阳性。CD133+鼻咽癌干细胞转染hTERTp/TK/pGL3或CMV/TK/pGL3后端粒酶活性降低;而ECV细胞端粒酶为阴性表达;CD133+鼻咽癌干细胞分别转染TK/pGL3、CMV/TK/pGL3和hTERTp/TK/pGL3后细胞存活率平均为(87.4±0.4)%、(20.5±0.4)%和(27.9±0.2)%,ECV对照细胞组转染TK/pGL3、CMV/TK/pGL3和hTERTp/TK/pGL3后细胞存活率平均为(90.7±0.1)%、(18.1±0.2)%和(86.2±0.1)%,hTERTp/TK/pGL3杀灭鼻咽癌CD133+干细胞效率明显高于ECV细胞组(P<0.01)。结论:hTERTp/TK/pGL3载体可以通过下调端粒酶活性靶向抑制端粒酶阳性的鼻咽癌CD133+干细胞。 Objective To explore the mechanism of targeted inhibition of hTERTp/TK/pGL3 vector on the telomerase activity and its killing effect on nasopharyngeal cancer stem cells.Methods The nasopharyngeal carcinaoma CD133+ stem cells,CD133-tumor cells,human umbilical vein endothelial cells(ECV cells)(control group) and nasopharyngeal carcinaoma SUNE unsorted cells were transfected by hTERTp/TK/pGL3 vector and its control vectors(CMV/TK/pGL3 and TK/pGL3).The telomerase avtivities of nasopharyngeal carcinaoma CD133+ stem cells and ECV cells were detected by Stretch PCR.The survival rates of CD133+stem cells and ECV cells were detected by MTT method.Results After culture for 7 d in vitro,the number of nasopharyngeal carcinaoma CD133+ stem cells was increased,the tumorigenicity test of CD133+ stem cells in vivo was positive.The telomerase activity of nasopharyngeal carcinaoma CD133+ stem cells was decreased after transfected by hTERTp/TK/pGL3 or CMV/TK/pGL3;the telomerase activity of EVC cells was negative.After transfected by TK/pGL3,CMV/TK/pGL3,and hTERTp/TK/pGL3,the survival rates of CD133+ stem cells were 87.4%±0.4%,20.5%±0.4%,and 27.9%±0.2%,respectively.After transfected by TK/pGL3,CMV/TK/pGL3,and hTERTp/TK/pGL3,the survival rates of ECV cells were 90.7%±0.1%,18.1%±0.2%,and 86.2%±0.1%,respectively.The efficiency of hTERTp/TK/pGL3 vector in killing CD133+ stem cells was higher than that of ECV cells(P0.01).Conclusion hTERTp/TK/pGL3 vector can targetedly inhibit the telomerase-positive nasopharyngeal carcinaoma CD133+ stem cells by down-regulation of telomerase activity.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期534-538,I0002,F0003,共7页 Journal of Jilin University:Medicine Edition
基金 广东省科技计划项目资助课题(2008B030301344)
关键词 鼻咽肿瘤 CD133+肿瘤干细胞 肿瘤靶向治疗 端粒酶 nasopharyngeal neoplasms CD133+tumor stem cells targeted tumor therapy telomerase
  • 相关文献

参考文献15

  • 1Zhang HB,Ren CP,Yang XY,et al.Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngealcarcinoma tissues[J].Histochem Cell Biol,2007,127(3):347-354.
  • 2Wang J,Guo LP,Chen LZ,et al.Identification of cancerstem cell-like side population cells in human nasopharyngealcarcinoma cell line[J].Cancer Res,2007,67(8):3716-3724.
  • 3Damek-Poprawa M,Volgina A,Korostoff J,et al.Targetedinhibition of CD133+cells in oral cancer cell lines[J].J DentRes,2011,90(5):638-645.
  • 4Takebe N,Harris PJ,Warren RQ,et al.Targeting cancerstem cells by inhibiting Wnt,notch,and Hedgehogpathways[J].Nat Rev Clin Oncol,2011,8(2):97-106.
  • 5Piccirillo SG,Reynolds BA,Zanetti N,et al.Bonemorphogenetic proteins inhibit the tumorigenic potential ofhuman brain tumour-initiating cells[J].Nature,2006,444(7120):761-765.
  • 6Fuchs D,Heinold A,Opelz G,et al.Salinomycin inducesapoptosis and overcomes apoptosis resistance in human cancercells[J].Biochem Biophys Res Commun,2009,390(3):743-749.
  • 7Shen CX,Wen Z,Qian YH,et al.Targeted gene therapy ofnasopharyngeal cancer in vitro and in vivo by enhancedthymidine kinase expression driven by human TERT promoterand CMV enhancer[J].J Exp Clin Cancer Res,2010,29(1):94.
  • 8徐芳,文忠,邱元正,肖健云,赵素萍,郭梦和.端粒酶启动子调控tk基因靶向性杀伤鼻咽癌细胞的实验研究[J].南方医科大学学报,2010,30(4):695-699. 被引量:4
  • 9牟少凤,文忠,郭梦和,谢民强,关小芳,申聪香.hTERT启动子调控TK基因靶向性杀伤鼻咽癌移植瘤的实验研究[J].解放军医学杂志,2009,34(2):155-158. 被引量:5
  • 10申聪香,文忠,钱宇虹,关小芳,牟少凤.增强型胸苷激酶基因表达载体的构建及其杀伤鼻咽癌细胞的实验研究[J].中华耳鼻咽喉头颈外科杂志,2010,45(5):414-419. 被引量:3

二级参考文献43

  • 1李帆,谭晓华,彭晓君,蔡红兵,胡大荣.人端粒酶反转录酶启动子的克隆与肿瘤靶向治疗的研究[J].第一军医大学学报,2005,25(2):207-211. 被引量:2
  • 2王丽娜,李卓,薛志刚,薛金锋,胡友金,周银,李剑,潘乾,夏昆,梁德生,夏家辉.用原核增强子提高hTERT启动子介导的基因表达[J].中华肿瘤防治杂志,2006,13(15):1125-1130. 被引量:6
  • 3王丽娜,张雅坤,周银,李剑,尹彪,李琼,潘乾,薛志刚,夏昆,梁德生,夏家辉.增强型自杀基因载体治疗宫颈癌的体外实验研究[J].中国医学工程,2006,14(6):567-570. 被引量:6
  • 4邱慧兵,周云峰,周福祥,谢丛华,骆志国,於海军,刘诗权.RNA干扰抑制Hep-2细胞人端粒酶逆转录酶基因表达对放射敏感性的影响[J].中华肿瘤杂志,2007,29(1):9-13. 被引量:9
  • 5Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 1997, 3(7): 730.
  • 6Al-Hajj M, Wicha MS, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(7): 3983.
  • 7Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63(18) : 5821.
  • 8Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bron chioalveolar stem cells in normal lung and lung cancer. Cell, 2005, 121(6) : 823.
  • 9Xin L, Lawsonn DA, Witte ON. The Scal cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate p rostate tumorigenesis. Proc Natl Acad Sci USA, 2005, 102(19): 6942.
  • 10Zhang HB, Ren CP, Yang XY, et al. Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem Cell Biol, 2007, 127(3) : 347.

共引文献24

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部